CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
China Anti-Cancer Association
2025-05-01
|
| Series: | Cancer Biology & Medicine |
| Online Access: | https://www.cancerbiomed.org/content/22/5/496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|